Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Lux

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Anticancer Research|August 6, 2005
Neoadjuvant chemotherapy in breast cancer: which diagnostic procedures can be used?C R Loehberg, M P Lux, S Ackermann, et al.
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Health Services Research and Health Economy - Quality Care Training in Gynaecology, with Focus On Gynaecological OncologyM P Lux, P A Fasching, C R Loehberg, et al.
Journal of Cancer Research and Clinical Oncology|April 5, 2008
Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapyP A Fasching, B Kollmannsberger, P L Strissel, et al.
Geburtshilfe Und Frauenheilkunde|February 9, 2016
Touch Imprint Cytology and Stereotactically-Guided Core Needle Biopsy of Suspicious Breast Lesions: 15-Year Follow-upR Schulz-Wendtland, P A Fasching, M R Bani, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2013
Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patientsN Harbeck, M Schmitt, C Meisner, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|August 8, 2015
[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation]M Beckmann, C Sell, M Aydogdu, et al.
Journal of Cancer Research and Clinical Oncology|February 12, 2008
Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancerM Schrauder, S Frank, P L Strissel, et al.
Geburtshilfe Und Frauenheilkunde|October 10, 2014
Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-SeR Schulz-Wendtland, M Bani, M P Lux, et al.
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Full Field Digital Mammography (FFDM) versus CMOS Technology versus Tomosynthesis (DBT) - Which System Increases the Quality of Intraoperative Imaging?R Schulz-Wendtland, G Dilbat, M Bani, et al.
Der Pathologe|November 9, 2018
[TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes]R Erber, A Hartmann, M W Beckmann, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Anticancer Research|August 6, 2005
Neoadjuvant chemotherapy in breast cancer: which diagnostic procedures can be used?C R Loehberg, M P Lux, S Ackermann, et al.
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Health Services Research and Health Economy - Quality Care Training in Gynaecology, with Focus On Gynaecological OncologyM P Lux, P A Fasching, C R Loehberg, et al.
Journal of Cancer Research and Clinical Oncology|April 5, 2008
Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapyP A Fasching, B Kollmannsberger, P L Strissel, et al.
Geburtshilfe Und Frauenheilkunde|February 9, 2016
Touch Imprint Cytology and Stereotactically-Guided Core Needle Biopsy of Suspicious Breast Lesions: 15-Year Follow-upR Schulz-Wendtland, P A Fasching, M R Bani, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2013
Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patientsN Harbeck, M Schmitt, C Meisner, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|August 8, 2015
[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation]M Beckmann, C Sell, M Aydogdu, et al.
Journal of Cancer Research and Clinical Oncology|February 12, 2008
Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancerM Schrauder, S Frank, P L Strissel, et al.
Geburtshilfe Und Frauenheilkunde|October 10, 2014
Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-SeR Schulz-Wendtland, M Bani, M P Lux, et al.
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Full Field Digital Mammography (FFDM) versus CMOS Technology versus Tomosynthesis (DBT) - Which System Increases the Quality of Intraoperative Imaging?R Schulz-Wendtland, G Dilbat, M Bani, et al.
Der Pathologe|November 9, 2018
[TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes]R Erber, A Hartmann, M W Beckmann, et al.
Pageof 5